Published in

Elsevier, Mental Health and Physical Activity, (9), p. 10-15, 2015

DOI: 10.1016/j.mhpa.2015.07.001

Links

Tools

Export citation

Search in Google Scholar

A commentary on the importance of controlling for medication use within trials on the effects of exercise on depression and anxiety

Journal article published in 2015 by Paquito Bernard ORCID, Marion Carayol ORCID
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

The aims of this commentary are to (1) identify the potential interactive effects of exercise with anxiety/depression medications, based on mechanistic or observational studies, (2) describe how studies dealt with use of antidepressant or anxiolytic participants' medications in their study design and analyses, based on a narrative review of Randomized Controlled Trials (RCTs), and (3) consider the implications for future research for assessing the use of medications within trials and using this information in analyses. Free Access: http://authors.elsevier.com/a/1RN926F6xNDcY6